AstraZeneca Pharma India Limited

NSEI:ASTRAZEN Stok Raporu

Piyasa değeri: ₹158.4b

AstraZeneca Pharma India Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Sanjeev Panchal

İcra Kurulu Başkanı

₹38.7m

Toplam tazminat

CEO maaş yüzdesi83.4%
CEO görev süresi1.8yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi1.3yrs
Yönetim Kurulu ortalama görev süresiless than a year

Son yönetim güncellemeleri

Recent updates

AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Earnings Haven't Escaped The Attention Of Investors

Sep 18
AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Earnings Haven't Escaped The Attention Of Investors

We Believe AstraZeneca Pharma India's (NSE:ASTRAZEN) Earnings Are A Poor Guide For Its Profitability

Jun 03
We Believe AstraZeneca Pharma India's (NSE:ASTRAZEN) Earnings Are A Poor Guide For Its Profitability

Why Investors Shouldn't Be Surprised By AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) P/S

May 22
Why Investors Shouldn't Be Surprised By AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) P/S

We Ran A Stock Scan For Earnings Growth And AstraZeneca Pharma India (NSE:ASTRAZEN) Passed With Ease

Apr 04
We Ran A Stock Scan For Earnings Growth And AstraZeneca Pharma India (NSE:ASTRAZEN) Passed With Ease

Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?

Nov 10
Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?

AstraZeneca Pharma India's (NSE:ASTRAZEN) Dividend Will Be Increased To ₹16.00

Jul 06
AstraZeneca Pharma India's (NSE:ASTRAZEN) Dividend Will Be Increased To ₹16.00

Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?

Jun 16
Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?

Increases to CEO Compensation Might Be Put On Hold For Now at AstraZeneca Pharma India Limited (NSE:ASTRAZEN)

Aug 02
Increases to CEO Compensation Might Be Put On Hold For Now at AstraZeneca Pharma India Limited (NSE:ASTRAZEN)

Here's Why I Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is An Interesting Stock

Feb 25
Here's Why I Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is An Interesting Stock

Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?

Feb 04
Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?

Declining Stock and Solid Fundamentals: Is The Market Wrong About AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?

Jan 18
Declining Stock and Solid Fundamentals: Is The Market Wrong About AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?

Announcing: AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Increased An Energizing 282% In The Last Five Years

Dec 31
Announcing: AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Increased An Energizing 282% In The Last Five Years

We're Not Counting On AstraZeneca Pharma India (NSE:ASTRAZEN) To Sustain Its Statutory Profitability

Dec 13
We're Not Counting On AstraZeneca Pharma India (NSE:ASTRAZEN) To Sustain Its Statutory Profitability

Here's Why We Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is Well Worth Watching

Nov 25
Here's Why We Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is Well Worth Watching

Here's What We Think About AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Pay

Nov 07
Here's What We Think About AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Pay

What Kind Of Investors Own Most Of AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?

Oct 20
What Kind Of Investors Own Most Of AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?

AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Sep 24
AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

If You Had Bought AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Three Years Ago, You Could Pocket A 298% Gain Today

Aug 28
If You Had Bought AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Three Years Ago, You Could Pocket A 298% Gain Today

What Did AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Take Home Last Year?

Aug 02
What Did AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Take Home Last Year?

CEO Tazminat Analizi

Sanjeev Panchal'un ücretlendirmesi AstraZeneca Pharma India'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

₹819m

Jun 30 2024n/an/a

₹959m

Mar 31 2024₹39m₹32m

₹2b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹2b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹21m₹5m

₹993m

Tazminat ve Piyasa: Sanjeev 'ın toplam tazminatı ($USD 458.59K ) Indian pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 481.61K ).

Tazminat ve Kazançlar: Sanjeev şirketinin tazminatı %20'den fazla artarken, şirketin kazancı geçen yıl %20'den fazla düştü.


CEO

Sanjeev Panchal (47 yo)

1.8yrs

Görev süresi

₹38,725,314

Tazminat

Dr. Sanjeev Kumar Panchal serves as Country President of AstraZeneca Pharma India Limited since January 01, 2023 and serves as its Managing Director since January 01, 2023. He serves as Director of AstraZe...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Sanjeev Panchal
MD, Country President & Director1.8yrs₹38.73mVeri yok
Bhavana Agrawal
Whole-Time Director & CFO1.1yrs₹30.59mVeri yok
Pratap Bhuvanagiri
Legal Counsel7.8yrs₹3.73mVeri yok
Manasa R.
Company Secretary & Compliance Officer2.3yrsVeri yokVeri yok
Smita Saha
Vice President of Human Resourcesno data₹12.28mVeri yok
Ayush Agarwal
Interim Business Unit Head of Oncology & Director of Commercial Excellence1.3yrsVeri yokVeri yok
Praveen Akkinepally
Head of Oncology Business Unitless than a yearVeri yokVeri yok
Vinay Sharma
Business Unit Head - Rare Disease unitless than a yearVeri yokVeri yok
Pankaj Jain
Legal Headno dataVeri yokVeri yok

1.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: ASTRAZEN 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.3 yıl), bu da yeni bir ekibin varlığını gösteriyor.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Sanjeev Panchal
MD, Country President & Director1.8yrs₹38.73mVeri yok
Bhavana Agrawal
Whole-Time Director & CFOless than a year₹30.59mVeri yok
Revathy Ashok
Independent Non-Executive Director7.9yrs₹1.20mVeri yok
Monica Widhani
Additional Independent Directorless than a yearVeri yokVeri yok
Hooi Chuah
Additional Non-Executive Directorless than a yearVeri yokVeri yok
Nirula Shilpa Divekar
Independent Non-Executive Chairperson of the Board2.9yrs₹1.30mVeri yok
Sylvia Lorena Ramon
Non-Executive Directorless than a yearVeri yokVeri yok
Jesus Javier Diaz Esteso
Additional Non-Executive Directorno dataVeri yokVeri yok

0.9yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ASTRAZEN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 0.9 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.